They found that in one patient, tumor organoids from the area of dysplasia at the tumor edge and invasive area shared common early driver mutations involving TP53 and APC, but evolved to have very different patterns of chromosomal aberrations and unique driver mutations. This evidence concerns the gene TP53 and neoplasm.